[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on targets for cancer drug development and developing and commercializing cancer therapies. The company's lead clinical PP2A inhibitor, LB-100, is well-tolerated in cancer patients at doses associated with anti-cancer activity. Its LB-100 has the potential to enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer. The company's lead compound, LB-100, also focuses on new field of cancer biology \u0096 activation lethality \u0096 that is advancing a new treatment paradigm. Its proof-of-concept clinical trials are in progress for colon, small cell lung, and sarcoma cancers. The company has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; license agreements with National Institute of Health and Moffitt Cancer Center; and collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group and Oncode Institute, as well as Roche and the Netherlands Cancer Institute for conducting new clinical trial in immune therapy unresponsive metastatic colon cancer. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 51, "title": "President, CEO & Chairman of the Board of Directors", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 71, "title": "VP & CFO", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric J. Forman J.D.", "age": 44, "title": "VP & COO", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.13, "open": 2.21, "dayLow": 2.19, "dayHigh": 2.21, "regularMarketPreviousClose": 2.13, "regularMarketOpen": 2.21, "regularMarketDayLow": 2.19, "regularMarketDayHigh": 2.21, "beta": -0.216, "volume": 3099, "regularMarketVolume": 3099, "averageVolume": 33445, "averageVolume10days": 2940, "averageDailyVolume10Day": 2940, "marketCap": 4925945, "fiftyTwoWeekLow": 1.58, "fiftyTwoWeekHigh": 4.42, "fiftyDayAverage": 2.3574, "twoHundredDayAverage": 2.512, "currency": "USD", "enterpriseValue": 4991663, "floatShares": 1978138, "sharesOutstanding": 2249290, "sharesShort": 11988, "sharesShortPriorMonth": 18581, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0053, "heldPercentInsiders": 0.20482, "heldPercentInstitutions": 0.0825, "shortRatio": 1.4, "shortPercentOfFloat": 0.0055, "bookValue": 0.22, "priceToBook": 9.954546, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -4690692, "trailingEps": -2.27, "lastSplitFactor": "1:6", "lastSplitDate": 1605830400, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LIXT", "underlyingSymbol": "LIXT", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "firstTradeDateEpochUtc": 1193319000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a941de37-b47d-353c-8260-973e88a724c1", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.19, "recommendationKey": "none", "totalCash": 3414263, "totalCashPerShare": 1.518, "quickRatio": 7.377, "currentRatio": 7.755, "returnOnAssets": -0.73973, "returnOnEquity": -1.3016701, "freeCashflow": -2062008, "operatingCashflow": -3811121, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-12"}]